Ever Fortune.AI Co (6841) Fair Value & Analysis
Healthcare · TW · Market cap 5.7B TWD
Fair value as of: Jun 24, 2026
Analysis
Ever Fortune.AI Co (6841) currently trades at 60.00 TWD, while our model-based Fair Value estimate is 14.46 TWD — implying the stock looks roughly 75.9% overvalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Ever Fortune.AI Co., Ltd., an cloud-based biomedical platform, provides medical artificial intelligence solutions and services in China. The company offers radiation therapy organ, head and neck organ delineation system, bone scintigraphy computer-aided detection platform, cerebral hemorrhage detection system, myocardial perfusion image analysis and reporting system, ECG analysis software, acute aortic syndrome, detection system, acute myocardial infarction detection software, heart-to-chest ratio estimation system, artificial intelligence assisted chest X-ray diagnosis system, bone age auxiliary diagnosis system, and image recording and transmission system. Ever Fortune.AI Co., Ltd. was founded in 1998 and is based in Taichung, Taiwan. Ever Fortune.AI Co., Ltd. is a subsidiary of An Ji Biomedical Corporation.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Ever Fortune.AI Co (6841) undervalued?
What is the fair value of 6841?
What is the quality score of 6841?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.